Skip to content
10-K

Annual Report

Pulse Biosciences, Inc. PLSE

0001437749-26-004724

← back to feed
Filed
Feb 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 67.99M sh
Capex FY 2025 · Dec 31, 2025 $315K
Capex FY 2025 · Dec 31, 2024 $125K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$54.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$36.34M
Cash And Equivalents FY 2025 · Dec 31, 2025 $80.74M
Cash And Equivalents FY 2025 · Dec 31, 2024 $118.04M
Stockholders Equity FY 2025 · Dec 31, 2025 $80.66M
Stockholders Equity FY 2025 · Dec 31, 2024 $114.86M
Stockholders Equity FY 2025 · Dec 31, 2023 $44.36M
Current Liabilities FY 2025 · Dec 31, 2025 $7.92M
Current Liabilities FY 2025 · Dec 31, 2024 $10.06M
Total Liabilities FY 2025 · Dec 31, 2025 $13.88M
Total Liabilities FY 2025 · Dec 31, 2024 $17.6M
Current Assets FY 2025 · Dec 31, 2025 $83.42M
Current Assets FY 2025 · Dec 31, 2024 $119.45M
Total Assets FY 2025 · Dec 31, 2025 $94.54M
Total Assets FY 2025 · Dec 31, 2024 $132.46M
Eps Basic FY 2025 · Dec 31, 2025 −$1.08
Eps Basic FY 2025 · Dec 31, 2024 −$0.92
Sga Expense FY 2025 · Dec 31, 2025 $32.03M
Sga Expense FY 2025 · Dec 31, 2024 $23.92M
Rd Expense FY 2025 · Dec 31, 2025 $44.72M
Rd Expense FY 2025 · Dec 31, 2024 $32.34M
Net Income FY 2025 · Dec 31, 2025 −$72.78M
Net Income FY 2025 · Dec 31, 2024 −$53.59M
Operating Income FY 2025 · Dec 31, 2025 −$76.94M
Operating Income FY 2025 · Dec 31, 2024 −$56.26M
Cost Of Revenue FY 2025 · Dec 31, 2025 $539K
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2025 $350K
Revenue FY 2025 · Dec 31, 2024 $0